Did Novo-Nordisk Win an Emmy?

September 15, 2025

Mish's Daily

By Mish Schneider

While NVO did not win an Emmy, the company has spent $96 million in Q2 alone on TV ads.

And I am sure if one queried a random group of actors, we might discover that taking one diet drug or another is integral to their vanity plan.

In June Novo spent $39.9 Million up from $24 million in May.

Given what is known and what isn’t public, a reasonable working estimate is that Novo Nordisk’s U.S. TV ad spend for prescription drugs in 2025 to date is in the low hundreds of millions of dollars—possibly in the range of $250-400 million for just its top GLP-1/weight loss ones, and higher if you include all branded drugs.

The future could be excellent for Novo.

The oral semaglutide developments are particularly important; if successful, an oral Wegovy dose for weight management would broaden use, improve patient compliance, and potentially open new market segments.

Novo’s positioning may shift from purely growth and scaling toward “smart growth” — doubling down on what works, streamlining what doesn’t, being more disciplined in spending and R&D.

Of course, we turn to the chart.

While the price has more to do to prove it has truly bottomed out, there are four interesting patterns to note.

Real Motion or the momentum indicator shows a STRONG bullish divergence with the red dots above the 200-DMA while the price remains far below its 200-DMA
Monday, the price gapped higher, clearing the top of all of last week’s price range.
On August 6th, the trough was made with a classic reversal bottoming formation.
The risk reward is amazing right here for all timeframes. Short-term trading and position swing trading.

South Park: The End of Obesity (Paramount+) shown on May 24, 2024, centered an episode around weight-loss drugs (by name, Ozempic), not Wegovy.

The skit pointed out that insurance companies do not cover the drugs making them unaffordable.

But the character does find an inexpensive alternative, “Lizzo.”

A line from the episode, “In case studies, 70% of patients on Lizzo no longer cared how much they weighed … Lizzo helps you eat everything you want and keep physical activity to a minimum.”

Educational purposes only, not official trading advice. 

Limited offer.

Real-Time Trading with Mish

Hey everyone!

It’s been a moment since I’ve been sharing my insights on @Slice_App_, and I’m excited to invite you to join me on this journey! For those of you who haven’t subscribed yet, here’s your chance to dive in.

This is the only service where you can get my trades and trade management.

It will not last forever.

TRADE with Mish in Real Time
Just like the old days
We are already up big money in a short time
More flexible with day trading included.
Exclusive content only available to my subscribers.

Click here to join now

Looking forward to seeing you there!

For more detailed trading information about our blended models, tools, and trader education courses, contact Rob Quinn, our Chief Strategy Consultant, to learn more.

-----Get your copy of
Plant Your Money Tree: A Guide to Growing Your Wealth

Grow Your Wealth Today and Plant Your Money Tree!